Julie Holder is an experienced preclinical scientist. Having 26 years of cell culture experience working with primary, immortalised and iPS cells with managerial responsibility of running a cellular group responsible for delivering predictive assays for attrition reduction. I am currently responsible for establishing and managing internal and external projects within Roslin Cell Sciences working to support the discovery and development of new assays utilising differentiated iPS cells.